ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

MYX Mayne Pharma Group Ltd

7.10
0.00 (0.00%)
09 May 2024 - Closed
Delayed by 20 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 30 June 2023 20162017201820192020202120222023
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Total Revenue 267.28M572.6M530.31M525.21M456.99M400.78M400.93M262.48M
Operating Income 47.41M127.97M-149.37M-337.9M-104.12M-230.15M-11.86M-233.15M
Pre Tax Income 49.84M115.94M-166.79M-353.72M-135.37M-263.89M-235.76M171.19M
Net Income 37.36M88.57M-133.98M-280.87M-92.79M-208.42M-281.29M117.25M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 0.0460.059-0.086-0.177-0.055-0.118-0.1590.068
EBIT 47.41M127.97M-149.37M-337.9M-104.12M-230.15M-11.86M279.98M
EBITDA 68.79M221.85M114.89M108.31M79.45M67.36M65.83M-164.12M

Your Recent History

Delayed Upgrade Clock